Abstract:Background: Ondansetron oral soluble film is designed to be applied on top of the tongue without requiring water to aid dissolution or swallowing, which is especially fitting for nausea and vomiting patients. Purpose: This study was conducted to compare the bioavailability of two 8 mg ondansetron oral soluble film formulations. Patients and methods: This randomized, open-label, two-period crossover study was performed under fasting conditions. A total of ten eligible subjects were randomly assigned at a 1: 1 ratio to receive a single 8 mg dose of the test and reference ondansetron oral soluble film formulations, followed by a 1-week washout period and administration of the alternate formulation. The concentrations of ondansetron were assayed using an liquid chromatographmass spectrometer/mass spectrometer (LC-MS/MS) method. For analysis of pharmacokinetic properties, including the peak concentration of T-max (C-max), AUC from time 0 (baseline) to t hours (AUC(0-t)), and AUC from baseline to infinity (AUC(0-infinity)), blood samples were obtained at intervals over the 24-hour period after studying drug administration. Tolerability was assessed by monitoring vital signs and laboratory tests (hematology, blood biochemistry, hepatic function, and urinalysis) and by questioning subjects about adverse events. Results: The mean (standard derivation [SD]) relative bioavailability was 96.5 (23.7%). The 90% confidence intervals (CIs) for the log-transformed ratios of C-max and AUC(0-t) were 84.71%-103.28% and 91.38%-108.60%, respectively (P>0.05). Similar results were found for the data without log-transformation. No statistically significant differences were found based on analysis of variance. No significant adverse events occurred or were reported during the study. Conclusion: As the 90% CIs based on the differences between the test and reference formulation were within the 80%-125% range for both the C-max and AUC(0-t), we concluded that the two formulations were bioequivalent with respect to the rate or the extent of absorption. Both formulations are well tolerated.

Study on the Dissolution of Ondansetron Hydrochloride Tablets of Different Manufacturers

Study on the dissolution of tamoxifen citrate tablets of different manufacturers in vitro

Comparison of External Dissolution among Four Kinds of Cefpodoxime Proxetil Tablets

Research on Dissolution Profiles of Compound Huangliansu Tablets from Different Manufacturers

Comparison for Determination of Two Different Diosmin Tablets

Comparison of Dissolution Rates of Levofloxacin Tablets Produced by 4 Manufactures

Study on Dissolution of Amidarone Hydrochloride Tablets

Study on the Dissolution of Flavones in Ginkgo Leaf Tablets Made by Different Manufacturers

Bioavailability and Bioequivalence of Ondansetron Orally Disintegrating Tablets and Conventional Tablets

[Comparative Study on Dissolution Behavior of Fufang Danshen Pian].

High Resolution Determination of Ondansetron in Human Plasma by HPLC and Pharmacokinetics of Orally Disintegrating Tablets

Bioequivalence Analysis of Ondansetron Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Two-Period Crossover Phase I Study

Pharmacokinetics and bioavailability study of two ondansetron oral soluble film formulations in fasting healthy male Chinese volunteers

Comparison of Carbamazepine Tablets from 9 Manufacturers in Content, Related Substances and Dissolution

Investigation on the Dissolution Behavior of Roxithromycin from Its Solid Dosage Forms

Comparative Study on the Dissolution Determination Methods of Ambroxol Hydrochloride Tablets

Evaluation of the Quality of Amlodipine and Atorvastatin Calcium Dispersible Tablets by Dissolution Curves in Different Mediums

Comparative Study on Exoteric Dissolution of Zuojin Pill and Its Similar Prescriptions

Investigation on the Dissolution of Dispersible Mosapride Citrate Tablets

Studies on Dissolution Test of Fenoprofen Calcium Tablets

Comparison of Dissolution Characteristics among Three Itraconazole Capsules in Vitro